{
    "title": "Controversies and consensus in Vitamin D \u2013 3rd Conference",
    "slug": "controversies-and-consensus-in-vitamin-d-3rd-conference",
    "aliases": [
        "/Controversies+and+consensus+in+Vitamin+D+\u2013+3rd+Conference+Sept+2019",
        "/12059"
    ],
    "tiki_page_id": 12059,
    "date": "2020-11-11",
    "categories": [
        "Overview for doctors",
        "Europe",
        "Consensus",
        "Conference"
    ],
    "tags": [
        "Conference",
        "Consensus",
        "Europe",
        "Overview for doctors",
        "diabetes",
        "high dose",
        "metabolic",
        "therapeutic intervention",
        "vitamin d",
        "vitamin k"
    ]
}


**Controversies in Vitamin D: A Statement From the Third International Conference** 

 **F1** 

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/conference-f1.jpg" alt="image" width="700">

 **T1** 

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/conference-t1.jpg" alt="image" width="400">

 **T2** <img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/conference-t2.jpg" alt="image">

 **F3** _

<img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/conference-f3.jpg" alt="image" width="400">

<div class="border" style="background-color:#f5f5f5;padding:15px;margin:10px 0;border-radius:5px;width:600px">

 **The many topics not discussed include** 

1. % activation of vitamin D in the cells rather than in the liver & kidneys

1. When are loading doses better than daily

1. The many months to plateau the response to a new supplementation level

1. Efficacy of other forms for Vitamin D, such as nanoemulsion

   * Including gut-friendly forms of vitamin D

1. Higher Vitamin D thresholds for some diseases

1. Some diseases reduce the levels of Vitamin D in the blood

1. Risk of Toxicity can be substantially reduce by adjusting cofactors 

   * such as reduce calcium, increase Vitamin K2

1. Microbiome interaction with Vitamin D

1. 4X range of response between individuals to both supplementation and UVB

</div>

Journal of Bone and Mineral Research DOI: 10.1002/jbm4.10417

Andrea Giustina,1 ® Roger Bouillon,2© Neil Binkley,3© Christopher Sempos,4 Robert A Adler,5 Jens Bollerslev,6 Bess Dawson-Hughes,7© Peter R Ebeling,8® David Feldman,9 Annemieke Heijboer,10 Glenville Jones,11 Christopher S Kovacs,12 Marise Lazaretti-Castro,13 Paul Lips,14 Claudio Marcocci,15 Salvatore Minisola,16© Nicola Napoli,17,18® Rene Rizzoli,19 Robert Scragg,20 John H White,21 Anna Maria Formenti,1 and John P Bilezikian22©

* 1Institute of Endocrine and Metabolic Sciences, San Raffaele, Vita-Salute University and IRCCS Hospital, Milan,, Italy

* 2Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases Metabolism and Ageing, KU Leuven, Leuven, Belgium 

* 3Osteoporosis Clinical Research Program on Aging, University of Wisconsin, Madison,WI, USA 

* 4Vitamin D Standardization Program LLC, Havre de Grace, MD, USA

* 5McGuire Veterans Affairs Medical Center and Virginia Commonwealth University School of Medicine, Richmond, VA, USA 

* 6Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, and Faculty of Medicine, University of Oslo, Oslo, Norway

* 7Jean Mayer USDA Nutrition Research Center on Aging, Tufts University, Boston, MA, USA 

* 8Department of Medicine, School of Clinical Sciences, Monash University, Calyton, Victoria, Australia 

* 9Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA

* 10Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam and University of Amsterdam, Amsterdam Gastroenterology & Metabolism, Amsterdam, The Netherlands

* 11Department of Biomedical and Molecular Sciences, Queen;s University, Kingston, Ontario, Canada 

* 12Faculty of Medicine, Memorial University of Newfoundland, St. John;s, Newfoundland and Labrador, Canada 

* 13Division of Endocrinology, Escola Paulista de Medicina-Universidade Federal de Sao Paulo (EPM-UNIFESP), Sao Paulo, Brazil 

* 14Department of Internal Medicine, Endocrine Section, Amsterdam University Medical Center, Amsterdam, The Netherlands 

* 15Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy 

* 16Department of Internal Medicine and Medical Disciplines, University of Rome “Sapienza”，Rome, Italy 

* 17Unit of Endocrinology and Diabetes, Campus Bio-Medico, University of Rome, Rome, Italy 

* 18Division of Bone and Mineral Diseases, Washington University in St. Louis, St. Louis, MO, USA 

* 19Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland 

* 20School of Population Health, University of Auckland, Auckland, New Zealand

* 21Department of Physiology, McGill University, Montreal, Quebec, Canada

* 22Department of Medicine, Endocrinology Division, College of Physicians and Surgeons, Columbia University, New York, NY, USA

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/controversies-in-vitamin-d-3rd-conference.pdf">Download the PDF from VitaminDWiki</a>** 

{{< toc >}}